We are live on
!
Find out more
Axsome Therapeutics
AXSM
AXSM
65 hedge funds and large institutions have $216M invested in Axsome Therapeutics in 2019 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,899% more capital invested
Capital invested by funds: $10.8M → $216M (+$205M)
375% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 8
189% more call options, than puts
Call options by funds: $25.4M | Put options by funds: $8.8M
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
86% more funds holding
Funds holding: 35 → 65 (+30)
44% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 9
31.69% more ownership
Funds ownership: 12.84% → 44.53% (+32%)
Holders
65
Holders Change
+30
Holders Change %
+85.71%
% of All Funds
1.41%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
38
Increased
13
Reduced
9
Closed
8
Calls
$25.4M
Puts
$8.8M
Net Calls
+$16.6M
Net Calls Change
+$16.4M
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$30.6M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$11.1M |
| 3 |
VMI
VHCP Management III
New York
|
+$9.92M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$9.75M |
| 5 |
RI
RTW Investments
New York
|
+$5.53M |
